Baili Tianheng: Sichuan Baili Tianheng Pharmaceutical Co., Ltd. voluntarily disclosed the announcement on the approval of the drug clinical trial for the treatment of systemic lupus erythematosus and rheumatoid arthritis for the GNC-038 tetraspecific antibody injection project